Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.
J Neurointerv Surg. 2013 Nov;5 Suppl 3:iii66-71. doi: 10.1136/neurintsurg-2012-010537. Epub 2012 Nov 17.
To assess predictors of outcome following endovascular treatment of small ruptured intracranial aneurysms (SRA).
Between 2004 and 2011, 91 patients with SRA (≤3 mm) were treated at our institution. Multivariate analysis was carried out to assess predictors of endovascular-related complications, aneurysm obliteration (>95%), recanalization and favorable outcome (Glasgow Outcome Scale 3-5).
Endovascular treatment was aborted in nine of 91 patients (9.9%). Procedure-related complications occurred in eight of 82 patients (9.8%) of which five were transient and three were permanent. Three patients (3.7%) undergoing endovascular treatment experienced an intraprocedural aneurysm rupture. Three of nine patients (33.3%) treated with stent- or balloon-assisted coiling experienced periprocedural complications compared with five of 73 patients (6.8%) receiving only coils or Onyx (p=0.039). There were no procedural deaths or rehemorrhages. Rates of recanalization and retreatment were 18.2% and 12.7%, respectively. No factors predicted initial occlusion or recanalization. In multivariate analysis, pretreatment factors predictive of a favorable outcome included younger age (OR 0.94; 95% CI 0.91 to 0.99, p=0.017), larger aneurysm size (OR 3.4; 95% CI 1.02 to 11.11, p=0.045), Hunt and Hess grade (OR 0.38; 95% CI 0.19 to 0.75, p=0.005) and location (OR 5.12; 95% CI 1.29 to 20.25, p=0.02). When assessing treatment and post-treatment variables, vasospasm was the only additional covariate predictive of a poor outcome (OR 5.90; 95% CI 1.34 to 25.93,p=0.019).
Most patients with SRA can be treated with endovascular therapy and have limited complications. Overall predictors of outcome for patients undergoing endovascular treatment of SRA include age, aneurysm size, Hunt and Hess grade, location and post-treatment vasospasm.
评估血管内治疗小型破裂颅内动脉瘤(SRA)的结果预测因素。
在 2004 年至 2011 年期间,我院共治疗 91 例 SRA(≤3mm)患者。采用多变量分析评估血管内相关并发症、动脉瘤闭塞(>95%)、再通和良好结局(格拉斯哥结局量表 3-5)的预测因素。
91 例患者中有 9 例(9.9%)中止血管内治疗。82 例患者中有 8 例(9.8%)发生与手术相关的并发症,其中 5 例为一过性,3 例为永久性。3 例(3.7%)接受血管内治疗的患者术中发生动脉瘤破裂。9 例接受支架或球囊辅助线圈治疗的患者中有 3 例(33.3%)发生围手术期并发症,而 73 例仅接受线圈或 Onyx 治疗的患者中有 5 例(6.8%)发生围手术期并发症(p=0.039)。无手术死亡或再出血。再通率和再治疗率分别为 18.2%和 12.7%。无因素预测初始闭塞或再通。多变量分析中,预测良好结局的预处理因素包括年龄较小(OR 0.94;95%CI 0.91-0.99,p=0.017)、动脉瘤较大(OR 3.4;95%CI 1.02-11.11,p=0.045)、Hunt 和 Hess 分级(OR 0.38;95%CI 0.19-0.75,p=0.005)和位置(OR 5.12;95%CI 1.29-20.25,p=0.02)。评估治疗和治疗后变量时,血管痉挛是唯一预测不良结局的附加协变量(OR 5.90;95%CI 1.34-25.93,p=0.019)。
大多数 SRA 患者可采用血管内治疗,并发症有限。接受 SRA 血管内治疗的患者的总体结局预测因素包括年龄、动脉瘤大小、Hunt 和 Hess 分级、位置和治疗后血管痉挛。